548 filings
Page 3 of 28
SC14D9C
73wjymtg jv02
1 Nov 22
Written communication relating to third party tender offer
9:27pm
SC TO-C
yugl5faj0vijehu ln7m
1 Nov 22
Information about tender offer
5:25pm
8-K
e7vdjn sjh
1 Nov 22
Abiomed Announces Second Quarter Revenue of $266 Million, Up 11% In Constant Currency*, Up 7% on a Reported Basis Year Over Year
8:14am
SC14D9C
2azwdxc m7v6ubrjmk
1 Nov 22
Written communication relating to third party tender offer
7:40am
8-K
7tqual3
1 Nov 22
Johnson & Johnson to Acquire Abiomed
7:39am
8-K
73wbbewcx lxutmktlkf
12 Aug 22
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
vhp7mxk
4 Aug 22
Results of Operations and Financial Condition
7:14am
DEFA14A
vssw5 265
28 Jun 22
Additional proxy soliciting materials
4:32pm
8-K
uzbhc mcz7hfidf
21 Jun 22
Other Events
7:12am
SD
13sbeqz83mm3hz6
20 May 22
Conflict minerals disclosure
4:10pm
8-K
x2n2gl r3
28 Apr 22
Abiomed Announces Fourth Quarter Record Revenue of $270 Million, Up 12% Year Over Year
7:30am
8-K
diq 54m4d2gzbx0
1 Apr 22
Departure of Directors or Certain Officers
4:30pm
8-K
10llln1
3 Feb 22
Abiomed Announces Record Revenue of $261 Million, Up 13% Year Over Year
7:19am
8-K
jx1hv32
28 Oct 21
Abiomed Announces Q2 Fy 2022 Revenue of $248 Million, Up 18% Year Over Year
7:26am
8-K
l64od3
13 Aug 21
Entry into a Material Definitive Agreement
4:01pm